澳股详情

本页面由Tiger Fintech (Singapore) Pte. Ltd.提供服务

Anagenics Ltd

0.006

0.000

成交量：7.50万

成交额：450.00

市值：297.79万

市盈率：-0.35

高：0.006

开：0.006

低：0.006

收：0.006

数据加载中...

总览公司新闻资讯公告

公司资料

公司名字：

Anagenics Ltd

交易所：

ASX

成立时间：

2004

员工人数：

- -

公司地址：

55 Clarence Street,Suite 204,Level 2,Sydney,New South Wales,Australia

官网：

http://www.cellmid.com.au

邮编：

2000

电话：

传真：

61 2 9221 8535

简介：

Cellmid Limited, a life sciences company, develops and commercializes diagnostic and therapeutic products for cancer and various chronic inflammatory conditions in Australia, the United States, and Japan. The company offers Midkine (MK) ELISA Kit, a cancer biomarker, and diagnostic and prognostic tool. It is also developing CAB102, a humanized monoclonal antibody for use in solid tumors; CAB101, a monoclonal antibody for the treatment of kidney injury, and inflammatory and fibrotic diseases; and CMK103, a recombinant human form of MK protein for use in cardiac ischemia. In addition, the company develops and sells over-the-counter products; and a range of FGF5 inhibitor hair growth products. Cellmid Limited was incorporated in 2004 and is based in Sydney, Australia.

{"basename":"/hans","ssrTDKData":{"titleTemplate":"%s - 老虎证券","title":"老虎证券全球投资理财平台| 一站式投资美股新股港股A股","description":"老虎证券助您一站式投资美股，新股，港股，A股等全球金融理财产品。新加坡华人最信赖的在线投资平台，现在加入即享低费用，24/5 无时差炒美股投资理财！","keywords":"老虎证券,老虎证券开户,老虎券商,老虎证券官网,老虎证券app,tigertrade老虎证券,股票,炒股,新加坡股票交易平台,投资,投资理财","social":{"ogDescription":"老虎证券助您一站式投资美股，新股，港股，A股等全球金融理财产品。新加坡华人最信赖的在线投资平台，现在加入即享低费用，24/5 无时差炒美股投资理财！","ogImage":"https://c1.itigergrowtha.com/portal5/static/media/og-logo.be62fbe1.png","ogUrl":"https://www.itiger.com/hans/stock/AN1.AU/company"},"companyName":"老虎证券"},"pageData":{"isMobile":false,"isTiger":false,"isTTM":true,"region":"SGP","license":"TBSG","edition":"fundamental","symbol":"AN1.AU","isAnalysisPage":false},"__swrFallback__":{"@#url:\"https://hq.skytigris.cn/stock_info/detail/global\",params:#delay:false,,method:\"POST\",data:#items:@#symbol:\"AN1.AU\",,,,,undefined,":{"symbol":"AN1.AU","market":"AU","secType":"STK","nameCN":"Anagenics Ltd","latestPrice":0.006,"timestamp":1751868720000,"preClose":0.006,"halted":0,"volume":74972,"delay":0,"nameEN":"Anagenics Ltd","floatShares":130868958,"shares":496320360,"eps":-0.017142,"marketStatus":"未开盘","change":0,"latestTime":"07-07 16:12:00 AEST","open":0.006,"high":0.006,"low":0.006,"amount":450,"amplitude":0,"askPrice":0.007,"askSize":4250000,"bidPrice":0.006,"bidSize":6706,"shortable":3,"etf":0,"ttmEps":-0.017142,"tradingStatus":0,"nextMarketStatus":{"tag":"开盘","tradingStatus":0,"beginTime":1751932800000},"marketStatusCode":0,"adr":0,"exchange":"ASX","adjPreClose":0.006,"openAndCloseTimeList":[[1751846400000,1751868000000]],"volumeRatio":0.6780096336317157,"lotSize":0},"@#url:\"https://hq.skytigris.cn/stock_info/fundamental/all\",params:#delay:false,,method:\"POST\",data:#items:@#symbol:\"AN1.AU\",,,,,undefined,":{"symbol":"AN1.AU","floatShares":130868958,"roa":"-27.30%","roe":"-135.49%","lyrEps":-0.018781,"volumeRatio":0.6780096336317157,"shares":496320360,"dividePrice":0,"high":0.006,"amplitude":0,"preClose":0.006,"low":0.006,"week52Low":0.004,"pbRate":"1.32","psRate":"0.41","week52High":0.009,"institutionHeld":0,"latestPrice":0.006,"committee":-0.996849,"eps":-0.017142,"divideRate":0,"volume":74972,"delay":0,"ttmEps":-0.017142,"open":0.006,"prevYearClose":0.008,"prevWeekClose":0.006,"prevMonthClose":0.005,"prevQuarterClose":0.005,"fiveDayClose":0.005,"twentyDayClose":0.006,"sixtyDayClose":0.008},"@#url:\"stock.company.info\",,undefined,":{"stockCompanyProfile":{"companyId":22744699,"yearFounded":2004,"address":"55 Clarence Street,Suite 204,Level 2,Sydney,New South Wales,Australia","zipCode":"2000","officePhone":"61 2 9221 6830","officeFax":"61 2 9221 8535"},"stockCompanyDetail":{"websiteUrl":"http://www.cellmid.com.au","stockEarnings":[{"period":"1week","weight":0.2},{"period":"1month","weight":0},{"period":"3month","weight":-0.25},{"period":"6month","weight":-0.25},{"period":"1year","weight":-0.25},{"period":"ytd","weight":-0.25}],"compareEarnings":[{"period":"1week","weight":-0.001},{"period":"1month","weight":0.0011},{"period":"3month","weight":0.123},{"period":"6month","weight":0.1366},{"period":"1year","weight":0.2152},{"period":"ytd","weight":0.1479}],"compareStock":{"symbol":"F100.AU","name":"BETASHARES FTSE 100 ETF"},"description":"Cellmid Limited, a life sciences company, develops and commercializes diagnostic and therapeutic products for cancer and various chronic inflammatory conditions in Australia, the United States, and Japan. The company offers Midkine (MK) ELISA Kit, a cancer biomarker, and diagnostic and prognostic tool. It is also developing CAB102, a humanized monoclonal antibody for use in solid tumors; CAB101, a monoclonal antibody for the treatment of kidney injury, and inflammatory and fibrotic diseases; and CMK103, a recombinant human form of MK protein for use in cardiac ischemia. In addition, the company develops and sells over-the-counter products; and a range of FGF5 inhibitor hair growth products. Cellmid Limited was incorporated in 2004 and is based in Sydney, Australia.","yearOnYearQuotes":[{"month":1,"riseRate":0.25,"avgChangeRate":-0.005208},{"month":2,"riseRate":0.5,"avgChangeRate":0.034268},{"month":3,"riseRate":0,"avgChangeRate":-0.168242},{"month":4,"riseRate":0.25,"avgChangeRate":-0.176731},{"month":5,"riseRate":0.25,"avgChangeRate":-0.148485},{"month":6,"riseRate":0.75,"avgChangeRate":0.131282},{"month":7,"riseRate":0.666667,"avgChangeRate":0.066138},{"month":8,"riseRate":0.666667,"avgChangeRate":0.101425},{"month":9,"riseRate":0.333333,"avgChangeRate":0.014493},{"month":10,"riseRate":0,"avgChangeRate":-0.126587},{"month":11,"riseRate":0,"avgChangeRate":-0.045977},{"month":12,"riseRate":0,"avgChangeRate":-0.095307}],"exchange":"ASX","name":"Anagenics Ltd","nameEN":"Anagenics Ltd"}},"@#url:\"https://hq.skytigris.cn/fundamental/company/manager/list\",params:#symbol:\"AN1.AU\",market:\"AU\",,,undefined,":null,"@#url:\"https://hq.skytigris.cn/fundamental/corporate_actions/details/AN1.AU\",params:#limit:5,,,undefined,":[],"@#url:\"https://hq.skytigris.cn/fundamental/dividend/history\",params:#symbol:\"AN1.AU\",market:\"AU\",,,undefined,":[]}}